Dublin, Feb. 21, 2025 (GLOBE NEWSWIRE) -- The "Liquid Biopsy for Cancer Diagnostics Market Opportunities and Strategies to 2034" report has been added to ResearchAndMarkets.com's offering.

This report describes and explains the liquid biopsy for cancer diagnostics market and covers 2019-2024, termed the historic ...

(UroToday.com) The 2025 APCCC Diagnostics annual meeting featured a session on how to monitor metastatic prostate cancer and ...

Nationally, about 208 Black men per 100,000 died from cancer, as opposed to 179 per 100,000 white men, the study said. About ...

A new study on circulating tumor DNA (ctDNA) testing for advanced breast cancer has unveiled encouraging results, with high ...

The 18-gene MyProstateScore 2.0 biomarker test was designed to reduce overdiagnosis of low-grade prostate cancers.

The "Europe Liquid Biopsy Market: Focus on End User and Country - Analysis and Forecast, 2024-2033" report has been added to ...

Rozlyn Khan accuses Hina Khan of exaggerating her stage 3 breast cancer diagnosis for attention. Rozlyn, a stage 4 cancer ...

Iowa's annual cancer report shows a troubling trend. What's making this year stand out and the concerns one cancer survivor has over research.

Scientists at the University of California San Diego have discovered an unusual but powerful tool in the fight against cancer ...